Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs

被引:9
|
作者
Bhagat, Priyanka [1 ]
Sachdeva, Ravinder Kaur [2 ,3 ]
Sharma, Prashant [1 ]
Sachdeva, Man Updesh Singh [1 ]
Chhabra, Sanjeev [1 ]
Sharma, Aman [2 ,3 ]
Das, Reena [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Ctr Excellence HIV Care, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India
关键词
HIV; HbA2; antiretroviral treatment; zidovudine; stavudine; tenofovir;
D O I
10.3109/23744235.2015.1089592
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Raised hemoglobin-A(2) (HbA(2)) is the diagnostic hallmark of beta-thalassemia trait (TT). Diagnostic difficulties may arise in HIV-positive patients on antiretroviral therapy (ART). We compared the effect of various antiretroviral drugs on HbA(2) levels. We attempted to determine which drugs elevate HbA(2) levels causing a false-positive diagnosis of TT and correlate the findings with red cell indices. Methods: A retrospective analysis of the records of an antenatal thalassemia screening program was carried out for 78 HIV-positive adults (70 antenatal women and 8 husbands) to study the effect of antiretroviral drugs on HbA(2) levels. Three had TT; 20 treatment-naive subjects constituted controls. The effects of zidovudine (36 cases), stavudine (7 cases), and tenofovir (12 cases) were evaluated. High-performance liquid chromatography was done for HbA(2) levels. Values of 3.5-3.9% were borderline and4% with hypochromic microcytosis was considered to be TT. Results: Twenty individuals not on ART had normal HbA(2)%. Three patients had TT and showed hypochromic microcytosis despite being on zidovudine. Fourteen of 55 patients on treatment (25.5%) had borderline HbA(2) values (mean 3.7%): 11 were on a zidovudine-based regimen and 3 on a stavudine-based regimen. One patient on zidovudine had 4.1% HbA(2) with normal Hb and severe macrocytosis (MCV 128.5 fl), leading to a false suspicion of TT. All patients on tenofovir had normal HbA(2). Hematological parameters, including mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and HbA(2) levels were increased due to antiretroviral drugs zidovudine and stavudine. Conclusion: Treatment-naive subjects and those on tenofovir showed no effect on HbA(2) levels compared with zidovudine and stavudine. A proportion of patients on zidovudine or stavudine had borderline elevated HbA(2) levels, which could lead to a false impression of beta TT.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 24 条
  • [21] Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England
    Daniel, Yvonne
    Cartwright, Ronwyn
    Rennie, Kristian
    Streetly, Allison
    Howard, Jo
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (04) : 607 - 611
  • [22] Effect of iron therapy on red cell indices and hemoglobin subtypes on patients with beta-thalassemia trait who developed iron-deficiency anemia: a tertiary center experience
    Sawsan M. Moeen
    Ahmad F. Thabet
    Marwa M. Thabet
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 741 - 745
  • [23] 2 MISSENSE MUTATIONS IN THE BETA-GLOBIN GENE CAN CAUSE SEVERE BETA-THALASSEMIA - HEMOGLOBIN MEDICINE LAKE (BETA-32[B14]LEUCINE-]GLUTAMINE 98[FG5]VALINE-]METHIONINE)
    COLEMAN, MB
    LU, ZH
    SMITH, CM
    ADAMS, JG
    HARRELL, A
    PLONCZYNSKI, M
    STEINBERG, MH
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02): : 503 - 509
  • [24] A Randomized Prospective Study to Assess the Effect of Vitamin E on Peroxiredoxin-2 As a Novel Antioxidant Marker in Young Beta-Thalassemia Major Patients on Different Chelation Therapy
    Abd el Mohsen, Mohamed
    Saber, Maha
    Adly, Amira
    Ismail, Eman
    Elalfy, Omar
    Islam, Elghamry
    Ibrahim, Fatma
    Elalfy, Mohsen Saleh
    BLOOD, 2018, 132